EP3143060A1 - Katalysatoren zur synthese von oxazolidinonverbindungen - Google Patents

Katalysatoren zur synthese von oxazolidinonverbindungen

Info

Publication number
EP3143060A1
EP3143060A1 EP15723462.6A EP15723462A EP3143060A1 EP 3143060 A1 EP3143060 A1 EP 3143060A1 EP 15723462 A EP15723462 A EP 15723462A EP 3143060 A1 EP3143060 A1 EP 3143060A1
Authority
EP
European Patent Office
Prior art keywords
carbon atoms
groups containing
isocyanate
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP15723462.6A
Other languages
English (en)
French (fr)
Other versions
EP3143060B8 (de
EP3143060B1 (de
Inventor
Thomas Ernst Müller
Christoph Gürtler
Susmit BASU
Irene LATORRE
Claudine Rangheard
Walter Leitner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covestro Intellectual Property GmbH and Co KG
Original Assignee
Covestro Deutschland AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covestro Deutschland AG filed Critical Covestro Deutschland AG
Publication of EP3143060A1 publication Critical patent/EP3143060A1/de
Application granted granted Critical
Publication of EP3143060B1 publication Critical patent/EP3143060B1/de
Publication of EP3143060B8 publication Critical patent/EP3143060B8/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/16Catalysts
    • C08G18/166Catalysts not provided for in the groups C08G18/18 - C08G18/26
    • C08G18/168Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/003Polymeric products of isocyanates or isothiocyanates with epoxy compounds having no active hydrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/16Catalysts
    • C08G18/22Catalysts containing metal compounds
    • C08G18/227Catalysts containing metal compounds of antimony, bismuth or arsenic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/74Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/76Polyisocyanates or polyisothiocyanates cyclic aromatic
    • C08G18/7614Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring
    • C08G18/7621Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring being toluene diisocyanate including isomer mixtures

Definitions

  • the present invention relates to a method for the selective production of oxazolidinone compounds comprising the step of reacting an isocyanate compound with an epoxide compound in the presence of an onium salt as catalyst and to the oxazolidinone compounds obtainable by said method.
  • the invention further relates to a method for the production of oligooxazolidinone and/or polyoxazolidinone compounds, comprising the step of reacting a polyisocyanate compound with a polyepoxide compound in the presence of said catalyst.
  • the invention further relates to oxazolidinone, oligooxazolidinone and/or polyoxazolidinone compounds with a regioselectivity to the 5-substituted l,3-oxazolidin-2-one regioisomer of > 78 %.
  • Oxazolidinones are widely used structural motifs in pharmaceutical applications, and the cycloaddition of epoxides and isocyanates seems to be a convenient one-pot synthetic route to produce them. Expensive catalysts, reactive polar solvents, long reaction times and low chemoselectivities are common in early reports for the synthesis of oxazolidinones (M. E. Dyen and D. Swern, Chem. Rev., 67, 197 (1967); X. Zhang and W. Chen, Chem. Lett., 39, 527 (2010); M.T. Barros and A.M.F. Phillips, Tetrahedron: Asymmetry, 21, 2746 (2010); H.-Y. Wu, J.-C.
  • Unpublished European Patent Application No. 12192611.7 relates to a method for the production of oxazolidinone compounds, comprising the step of reacting an isocyanate compound with an epoxide compound in the presence of a Lewis acid catalyst.
  • a Lewis acid catalyst The use of onium catalysts is disclosed. But neither activities nor selectivities with regard to the substitution pattern of the onium salts have been disclosed.
  • an antimony catalyst Pl SbBr
  • EP 0296450 discloses a method for the production of oligomeric oxazolidinone containing polyepoxides from bisepoxides and diisocyanates. It is required that the used bisepoxides carry hydroxy-groups corresponding to an OH-number of at least 2 and the molar ratio between the epoxide and isocyanate group within the diepoxides and diisocyanates is 1.4 up to 2.5. The reaction is carried out at temperatures between 140°C and 180°C.
  • the catalysts claimed are alkyl- and aryl- substituted phosphonium salts; in the examples tetrabutylphosphonium bromide and benzyltriphenylphosphonium bromide are used.
  • EP 0343064 discloses a method for preparing a thermosettable resin from polyisocyanate, polyepoxide and catalyst.
  • the catalysts used are tin compounds as well as stibonium and phosphonium salts.
  • a high selectivity to oxazolidinone in comparison to isocyanurate is observed.
  • the regioselectivity is not discussed.
  • US 3687897 discloses a process for the preparation of oxazolidinones by reacting an isocyanate with an epoxide in presence of a phosphonium catalyst such as tetrabutylphosphonium bromide.
  • a phosphonium catalyst such as tetrabutylphosphonium bromide.
  • the examples disclose the use of a tetrabutylphosphonium bromide or iodide catalyst.
  • the influence of the substituents on the phosphonium salt has not been discussed.
  • Phosphonium salts having three phenyl substituents at the phosphorous atom are deemed inactive with regard to the reaction of isocyanate and epoxide. The regio- and chemoselectivity of the reaction is not discussed.
  • WO 86/06734 Al discloses a process for the preparation of polyisocyanurate-based polyoxazolidinone polymers containing relatively small proportions of trimerized polyisocyanates.
  • the amount of isocyanurate compounds is below 15 mol-%.
  • the catalysts used are organoantimony iodide salts. The regioselectivity of the reaction is not discussed.
  • Such undesired side reactions include for example the trimerisation of isocyanate to isocyanurate groups, the formation of carbodiimides and homo-polymers of the epoxides.
  • the specifications concerning a high chemoselectivity to the oxazolidinone compound are particularly stringent, if polyoxazolidinone compounds with an almost linear polymer backbone and thermoplastic properties are desired.
  • the formation of isocyanurate groups should be supressed as this side reaction may result in crosslinking of the polymer chains.
  • the use of such special onium salts leads to a high rate in the reaction of isocyanates and epoxides and enables the production of the oxazolidinone compounds with high chemoselectivity in combination with the desired regioselectivity towards the 5-substituted l,3-oxazolidin-2-one regioisomer of > 78 %.
  • the substitution pattern of the onium cation determines the activity and selectivity of the catalysts.
  • the subject matter of the present invention is a method for the production of oxazolidinone compounds, comprising the step of reacting an isocyanate compound with an epoxide compound in the presence of a catalyst, characterized in that the catalyst is represented by the general formula (I)
  • M is phosphorous or antimony
  • Rl), (R2), (R3), (R4) are independently of one another selected from the group comprising linear or branched alkyl groups containing 1 to 22 carbon atoms, optionally substituted with heteroatoms and/or heteroatom containing substituents, cycloaliphatic groups containing 3 to 22 carbon atoms, optionally substituted with heteroatoms and/or heteroatom containing substituents, CI to C3 alkyl- bridged cycloaliphatic groups containing 3 to 22 carbon atoms, optionally substituted with heteroatoms and/or heteroatom containing substituents and aryl groups containing 6 to 18 carbon atoms, optionally substituted with one or more alkyl groups containing 1 to 10 carbon atoms and/or heteroatom containing substituents and/or heteroatoms,
  • (R4) is different from (Rl), (R2), and (R3) and
  • branched alkyl groups containing 3 to 22 carbon atoms preferably 3 to 6 carbon atoms, particularly preferred 4 carbon atoms, cycloaliphatic groups containing 3 to 22 carbon atoms, preferably 3 to 15 carbon atoms, particularly preferred 3 to 8 carbon atoms, CI to C3 alkyl-bridged cycloaliphatic groups containing 3 to 22 carbon atoms, preferably 3 to 15 carbon atoms, particularly preferred 3 to 12 carbon atoms and aryl groups, containing 6 to 18 carbon atoms, optionally substituted with one or more alkyl groups containing 1 to 10 carbon atoms and/or heteroatom containing substituents and/or heteroatoms,
  • (Rl), (R2) are aryl groups containing 6 to 18 carbon atoms preferably 6 carbon atoms,
  • Y is a halide, carbonate, nitrate, sulphate or phosphate anion and
  • n is an integer of 1, 2 or 3.
  • oxazolidinone compound is meant to denote oxazolidinone compounds obtainable by the reaction of an isocyanate compound with an epoxide compound.
  • oxazolidinone compound is meant to include polyoxazolidinone compounds with at least two oxazolidinone moieties in the molecule obtainable by the reaction of a polyisocyanate with a polyepoxide.
  • isocyanate compound is meant to denote monoisocyanate compounds, polyisocyanate compounds (having two or more NCO groups), NCO-terminated biuret, isocyanurates, uretdiones, carbamates and NCO-terminated prepolymers.
  • monoisocyanate compound is meant to denote isocyanate compounds having one isocyanate group.
  • polyisocyanate compound is meant to denote isocyanate compounds having at least two isocyanate groups.
  • diisocyanate compound is meant to denote polyisocyanate compounds having two isocyanate groups.
  • epoxide compound is meant to denote monoepoxide compounds, polyepoxide compounds (having two or more epoxide groups) and epoxide terminated prepolymers.
  • monoepoxide compound is meant to denote epoxide compounds having one epoxy group.
  • polyepoxide compound is meant to denote epoxide compounds having at least two epoxy groups.
  • diepoxide compound is meant to denote epoxide compounds having two epoxy groups.
  • onium salt is meant to denote the combination of a particular phosphonium and stibonium cation with a suitably chosen anion.
  • Suitable monoisocyanate compounds are methyl isocyanate, ethyl isocyanate, n-propyl isocyanate, isopropyl isocyanate, n-butyl isocyanate, isobutyl isocyanate, tert-butyl isocyanate, n- pentyl isocyanate, n-hexyl isocyanate, cyclohexyl isocyanate, ⁇ -chlorohexamethylene isocyanate, n-heptyl isocyanate, n-octyl isocyanate, iso-octyl isocyanate, 2-ethyl hexyl isocyanate, 2-norbornyl methyl isocyanate, nonyl isocyanate, 2,3,4-trimethylcyclohexyl isocyanate, 3,3,5- trimethylcyclohexyl isocyanate, decyl isocyanate, undecyl iso
  • Preferred monoisocyanate compounds are benzyl isocyanate, phenyl isocyanate, ortho-, meta-, para-tolyl isocyanate, dimethylphenyl isocyanate (technical mixture and individual isomers), 4- cyclohexylphenyl isocyanate and ortho-, meta-, /jara-methoxyphenyl isocyanate.
  • a mixture of two or more of the aforementioned monoisocyanate compounds can also be used.
  • polyisocyanate compounds are tetramethylene diisocyanate, hexamethylene diisocyanate (HDI), 2-methylpentamethylene diisocyanate, 2,2,4-trimethylhexamethylene diisocyanate (THDI), dodecamethylene diisocyanate, 1 ,4-diisocyanatocyclohexane, 3- isocyanatomethyl-3,3,5-trimethylcyclohexyl isocyanate (isophorone diisocyanate, IPDI), 4,4'- diisocyanatodicyclohexylmethane (H12-MDI), 4,4'-diisocyanato-3,3'-dimethyldicyclohexylmethane, 4,4'-diisocyanato-2,2-dicyclohexylpropane, poly(hexamethylene diisocyanate), octamethylene diisocyanate, tolylene-a,4-diisocyanate,
  • Preferred polyisocyanates are hexamethylene diisocyanate (HDI), 3-isocyanatomethyl-3,3,5- trimethylcyclohexyl isocyanate (isophorone diisocyanate, IPDI), 4,4'- diisocyanatodicyclohexylmethane (H12-MDI), 2,4- or 2,5- or 2,6-diisocyanatotoluene (TDI) or mixtures of these isomers, 4,4'-, 2,4'- or 2,2'-diisocyanatodiphenylmethane (MDI) or mixtures of these isomers.
  • HDI hexamethylene diisocyanate
  • IPDI isophorone diisocyanate
  • H12-MDI 4,4'- diisocyanatodicyclohexylmethane
  • TDI 2,4- or 2,5- or 2,6-diisocyanatotoluene
  • MDI 4,4
  • a mixture of two or more of the aforementioned polyisocyanates can also be used.
  • monoepoxide compounds are ethylene oxide, propylene oxide, 1,2-butene oxide, 2,3- butene oxide, butadiene monoepoxide, 1,2-hexene oxide, cyclohexene oxide, vinylcyclohexene monoxide, limonene monoxide, oxides of C10 - C18 alpha-olefins, styrene oxide, the epoxides of unsaturated fatty acid CI - CI 8 alkyl esters, methyl glycidyl ether, ethyl glycidyl ether, propyl glycidyl ether, butyl glycidyl ether, pentyl glycidyl ether, hexyl glycidyl ether, cyclohexyl glycidyl ether, octyl glycidyl ether, 2-ethylhexyl glycidyl
  • Preferred monoepoxide compounds are ethylene oxide, propylene oxide, 1,2-butene oxide, 2,3- butene oxide, styrene oxide, butyl glycidyl ether, benzyl glycidyl ether, phenyl glycidyl ether, p- tolyl glycidyl ether, 4-tert-butylphenyl glycidyl ether.
  • a mixture of the aforementioned monoepoxide compounds can also be used.
  • Diepoxide compounds are for example butadiene diepoxide, vinylcyclohexene diepoxide, limonene diepoxide, the diepoxides of double unsaturated fatty acid CI - CI 8 alkyl esters, ethylene glycol diglycidyl ether, di(ethylene glycol) diglycidyl ether, poly(ethylene glycol) diglycidyl ether, propylene glycol diglycidyl ether, di(propylene glycol) diglycidyl ether, poly(propylene glycol) diglycidyl ether, neopentyl glycol diglycidyl ether, polybutadiene diglycidyl ether, 1,6-hexanediol diglycidyl ether, hydrogenated bisphenol-A diglycidyl ether, 1 ,2-dihydroxybenzene diglycidyl ether, resorcinol diglycidyl ether, 1 ,4-dihydroxy
  • Preferred diepoxide compounds are butadiene diepoxide, the diepoxides of double unsaturated fatty acid CI - CI 8 alkyl esters, ethylene glycol diglycidyl ether, di(ethylene glycol) diglycidyl ether, poly(ethylene glycol) diglycidyl ether, propylene glycol diglycidyl ether, di(propylene glycol) diglycidyl ether, poly(propylene glycol) diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6- hexanediol diglycidyl ether, hydrogenated bisphenol-A diglycidyl ether, 1 ,2-dihydroxybenzene diglycidyl ether, resorcinol diglycidyl ether, 1 ,4-dihydroxybenzene diglycidyl ether, bisphenol-A diglycidyl ether, diglycidyl o-phthalate,
  • a mixture of two or more the aforementioned diepoxides can also be used.
  • Polyepoxide compounds are for example glycerol polyglycidyl ether, trimethylolpropane polyglycidyl ether, pentaerythritol polyglycidyl ether, diglycerol polyglycidyl ether, polyglycerol polyglycidyl ether, sorbitol polyglycidyl ether.
  • a mixture of one or more polyepoxide compounds and/or one or more of the aforementioned diepoxide compounds can also be used.
  • Onium salts within the scope of the invention are salts represented by formula (I)
  • M is phosphorous or antimony
  • Rl), (R2), (R3), (R4) are independently of one another selected from the group comprising linear or branched alkyl groups containing 1 to 22 carbon atoms, optionally substituted with heteroatoms and/or heteroatom containing substituents, cycloaliphatic groups containing 3 to 22 carbon atoms, optionally substituted with heteroatoms and/or heteroatom containing substituents, CI to C3 alkyl- bridged cycloaliphatic groups containing 3 to 22 carbon atoms, optionally substituted with heteroatoms and/or heteroatom containing substituents and aryl groups containing 6 to 18 carbon atoms, optionally substituted with one or more alkyl groups containing 1 to 10 carbon atoms and/or heteroatom containing substituents and/or heteroatoms,
  • (R4) is different from (Rl), (R2), and (R3) and
  • branched alkyl groups containing 3 to 22 carbon atoms preferably 3 to 6 carbon atoms, particularly preferred 4 carbon atoms, cycloaliphatic groups containing 3 to 22 carbon atoms, preferably 3 to 15 carbon atoms, particularly preferred 3 to 8 carbon atoms CI to C3 alkyl-bridged cycloaliphatic groups containing 3 to 22 carbon atoms, preferably 3 to 15 carbon atoms, particularly preferred 3 to 12 carbon atoms and aryl groups, containing 6 to 18 carbon atoms, optionally substituted with a heteroatom containing group, whereas
  • (Rl), (R2) are aryl groups containing 6 to 18 carbon atoms preferably 6 carbon atoms,
  • Y is a halide, carbonate, nitrate, sulphate or phosphate anion and
  • n is an integer of 1, 2 or 3.
  • M of formula (I) is phosphorous.
  • (Rl), (R2), (R3) of formula (I) independently of one another are aryl groups containing 6 to 18 carbon atoms, preferably (Rl), (R2), (R3) of formula (I) are each phenyl groups.
  • (R4) of formula (I) is selected from the group comprising branched alkyl groups containing 3 to 6 carbon atoms, cycloaliphatic groups containing 3 to 8 carbon atoms, CI to C3 alkyl-bridged cycloaliphatic groups containing 1 to 12 carbon atoms and aryl groups, containing 6 to 18 carbon atoms, optionally substituted with a heteroatom containing group.
  • R4 of formula (I) is selected from the group comprising branched alkyl groups containing 3 to 6 carbon atoms, cycloaliphatic groups containing 3 to 8 carbon atoms, CI to C3 alkyl-bridged cycloaliphatic groups containing 3 to 12 carbon atoms and aryl groups, containing 6 carbon atoms which are substituted with a heteroatom containing group.
  • R4 of formula (I) is selected from the group comprising branched alkyl groups containing 3 to 6 carbon atoms, cycloaliphatic groups containing 3 to 8 carbon atoms, CI to C3 alkyl-bridged cycloaliphatic groups containing 3 to 12 carbon atoms and phenyl, substituted with at least one heteroatom containing group, wherein the heteroatom is selected from O, N and/or S.
  • R4 of formula (I) is selected from the group comprising of branched alkyl groups containing 3 to 6 carbon atoms, cycloaliphatic groups containing 3 to 8 carbon atoms, CI to C3 alkyl-bridged cycloaliphatic groups containing 3 to 12 carbon atoms and phenyl, substituted with a O-methyl, O-ethyl, O-propyl, O-butyl, O-phenyl, N-(methyl)2-, N- (ethyl)2-, N-(phenyl)2, S- methyl, S-ethyl, S-propyl, S-butyl, or S-phenyl- group.
  • R4 of formula (I) is selected from z-propyl, z-butyl, sec- butyl, i-butyl, n-pentyl, z o-pentyl, neo-pentyl, n-hexyl, 2-hexyl, 3-hexyl, 2-ethyl-hexyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, CH 2 -cyclopentyl, CH 2 -cyclohexyl, CH 2 - cycloheptyl, CH 2 -norbornyl, CH 2 -bicyclo-[2.2.1]-heptyl, CH 2 -adamantyl, CH 2 -bicyclo-[2.2.2]- octyl, CH 2 -twistyl, CH 2 -bicyclo-[3.3.3]-undecyl,
  • a catalyst of formula (I) is used, wherein M is phosphorous, ( l), (R2) and (R3) are each phenyl groups and
  • R4 is selected from the group comprising branched alkyl groups containing 3 to 22 carbon atoms, preferably 3 to 6 carbon atoms, particularly preferred 4 carbon atoms, cycloaliphatic groups containing 3 to 22 carbon atoms, preferably 3 to 15 carbon atoms, particularly preferred 3 to 8 carbon atoms, CI to C3 alkyl-bridged cycloaliphatic groups containing 3 to 22 carbon atoms, preferably 3 to 15 carbon atoms, particularly preferred 3 to 12 carbon atoms and aryl groups, containing 6 to 18 carbon atoms, optionally substituted with a heteroatom containing group,
  • Y is a halide, carbonate, nitrate, sulphate or phosphate anion, preferably a halide or carbonate anion, more preferred chloride, bromide or carbonate and
  • n is an integer of 1, 2 or 3.
  • M is phosphorous
  • (Rl), (R2) and (R3) are each phenyl groups and
  • R4 is selected from the group comprising z ' -propyl, z ' -butyl, sec-butyl, i-butyl, n-pentyl, z o-pentyl, neo-pentyl, n-hexyl, 2-hexyl, 3-hexyl, 2-ethyl-hexyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, CH2-cyclopentyl, CH2-cyclohexyl, CH2-cycloheptyl, CH2-norbornyl, CH2-bicyclo- [2.2.1]-heptyl, CH 2 -adamantyl, CH 2 -bicyclo-[2.2.2]-octyl, CH 2 -twistyl, CH 2 -bicyclo-[3.3.3]- undecyl, 2-methoxyphenyl, 4-methoxypheny
  • Y is a halide, carbonate, nitrate, sulphate or phosphate anion, preferably a halide or carbonate anion, more preferred chloride, bromide or carbonate and
  • n is an integer of 1, 2 or 3.
  • M is phosphorous
  • (Rl), (R2) and (R3) are each phenyl groups and
  • (R4) is selected from the group comprising cyclopentyl, cyclohexyl, CH2-adamantyl, 2- methoxyphenyl and 4-methoxyphenyl,
  • Y is a halide, carbonate, nitrate, sulphate or phosphate anion, preferably a halide or carbonate anion, more preferred chloride, bromide or carbonate and
  • n is an integer of 1, 2 or 3.
  • the isocyanate compound is selected from benzyl isocyanate, phenyl isocyanate, ortho-, meta-, para-tolyl isocyanate, dimethylphenyl isocyanate (technical mixture and individual isomers), 4-cyclohexylphenyl isocyanate and/or ortho-, meta-, /jara-methoxyphenyl isocyanate and the epoxide compound is selected from ethylene oxide, propylene oxide, 1,2-butene oxide, 2,3- butene oxide, styrene oxide, butyl glycidyl ether, benzyl glycidyl ether, phenyl glycidyl ether, p- tolyl glycidyl ether and/or 4-tert-butylphenyl glycidyl ether.
  • the diisocyanate compound is selected from hexamethylene diisocyanate (HDI), 3- isocyanatomethyl-3,3,5-trimethylcyclohexyl isocyanate (isophorone diisocyanate, IPDI), 4,4'- diisocyanatodicyclohexylmethane (H12-MDI), 2,4- or 2,5- or 2,6-diisocyanatotoluene (TDI) or mixtures of these isomers and/or 4,4'-, 2,4'- or 2,2'-diisocyanatodiphenylmethane (MDI) or mixtures of these isomers and the diepoxide compound is selected from butadiene diepoxide, the diepoxides of double unsaturated fatty acid CI - CI 8 alkyl esters, ethylene glycol diglycidyl ether, di( ethylene glycol) diglycid
  • the method according to the invention is performed in the presence of a solvent.
  • Suitable solvents are high-boiling non-protic solvents such as N-methylpyrrolidone (NMP), N-ethylpyrrolidone, cyclic ethylene carbonate, cyclic propylene carbonate, sulfolane, chlorobenzene, the different isomers of dichlorobenzene, the different isomers of trichlorobenzene, decalin, hexamethylphosphoramide, dimethylformamide, N,N-dimethylacetamide (DMAc), dimethyl sulfoxide or mixtures of one or more of the aforementioned solvents among each other or with further non-protic solvents.
  • Preferred solvents are NMP, sulfolane and DMAc.
  • the reaction is conducted in the absence of a solvent.
  • the reaction mixture contains only the epoxide compound(s), the isocyanate compound(s) and the onium salt(s) as well as the oxazolidinone compound formed during the reaction.
  • the isocyanate compound may be added to the epoxide compound in a continuous or step-wise manner with two or more individual addition steps in the step-wise addition wherein in each individual addition step the amount of isocyanate compound added is ⁇ 50 weight-% of the total amount of isocyanate compound to be added.
  • This is to be understood in such a way that during the course of the reaction the isocyanate compound is added to the reaction mixture containing the epoxide compound continuously or in the aforementioned step-wise manner. Included is also the case that the isocyanate compound is added via a syringe pump, dripping funnel or other continuous or semi-continuous devices where the isocyanate is brought into the reaction mixture.
  • the reaction should be essentially complete shortly after the end of the addition of the isocyanate compound.
  • the isocyanate compound is added continuously to the reaction mixture.
  • Continuous in the meaning of the invention means that the isocyanate compound is added to the reaction mixture over a defined period of time, while at the same time any isocyanate compound present in the reaction mixture is converted to the oxazolidinone compound.
  • the rate of isocyanate addition is smaller than or equal to the maximum rate, with which the isocyanate compound can be converted under these reaction conditions to the oxazolidinone compound in order to avoid accumulation of NCO groups in the reaction mixture.
  • the actual concentration of NCO groups in the reaction mixture may be observed, for example, by in-situ IR spectroscopy. If the NCO group concentration is observed to increase above a set value, the rate of isocyanate addition is reduced.
  • the isocyanate compound is added to the reaction mixture (consisting of epoxide compound, isocyanate compound, onium salt and oxazolidinone compound, but not considering solvent, if present) with such an addition rate that the concentration of the isocyanate compound in the reaction mixture is ⁇ 40 weight-%, preferably ⁇ 20 weight-% and more preferred ⁇ 15 weight-%.
  • the amount of isocyanate compound added in each individual addition step is > 0.1 weight-% to ⁇ 50 weight-% of the total amount of isocyanate compound to be added.
  • the amount of isocyanate compound added per individual addition step is > 1.0 weight- %> to ⁇ 40 weight-%>, more preferred > 5.0 weight-%) to ⁇ 35 weight- %> of the total amount of isocyanate compound to be added.
  • the time intervals between each individual addition of isocyanate compound to the reaction mixture is chosen in such a way that the concentration of the isocyanate compound in the reaction mixture at any given point in time is ⁇ 40 weight-%, preferably ⁇ 20 weight-% and more preferred ⁇ 15 weight-%.
  • the actual concentration of NCO groups in the reaction mixture may be observed, for example, by in-situ IR spectroscopy. If the NCO group concentration is observed to increase above a set value, the time interval between the addition steps is increased.
  • the isocyanate compound is an isocyanate compound with two or more NCO groups per molecule, preferably with two NCO groups per molecule
  • the epoxide compound is an epoxide compound with two or more epoxy groups per molecule, preferably with two epoxide groups per molecule.
  • the method according to the invention is performed for example at temperatures of > 130 °C to
  • ⁇ 280 °C preferably at a temperature of > 140 °C to ⁇ 240 °C, most preferred at a temperature of ⁇ 155 °C to ⁇ 210 °C.
  • the catalyst according to formula (I) is present in an amount of > 0.0001 mol-%> to ⁇ 2.0 mol-%>, relative to the amount of isocyanate compound to be added to the reaction mixture.
  • the catalyst is present in an amount of > 0.001 mol-%> to
  • the oxazolidinone product is obtained with a chemoselectivity SOXA, given as the ratio of the molar amount of oxazolidinone moieties to the sum of the molar amount of oxazolidinone moieties and the molar amount of isocyanurate groups, of > 88 %>, preferably > 95 % and particularly preferred > 99 %.
  • the molar ratio can be determined, for example, using high performance liquid chromatography (HPLC) or NMR spectroscopy.
  • HPLC high performance liquid chromatography
  • NMR spectroscopy One method for determining the chemoselectivity SOXA is described below in the methods.
  • the oxazolidinone product is obtained with a regioselectivity towards the 5-substituted l,3-oxazolidin-2-one regioisomer of > 78 %>, preferably > 80 % and particularly preferred > 88 %.
  • the regioselectivity RS-OXA is given as the ratio of the molar fraction of 5-substituted l,3-oxazolidin-2-one moieties to the sum of the molar fractions of 5-substituted and 4-substituted l,3-oxazolidin-2-one moieties.
  • the molar fraction of the 5-substituted and 4-substituted l ,3-oxazolidin-2-one regioisomers can be determined, for example, using high performance liquid chromatography (HPLC) or NMR spectroscopy.
  • HPLC high performance liquid chromatography
  • NMR spectroscopy One method for determining the regioselectivity RS-OXA is described below in the methods.
  • the present invention is further directed towards an oligomeric or polymeric oxazolidinone compound, obtainable by a method according to the invention using an isocyanate compound with at least two NCO groups per molecule, preferably two NCO groups per molecule, and an epoxide compound with at least two epoxy groups per molecule, preferably two epoxy groups per molecule, comprising at least one unit derived from the isocyanate compound and at least two units derived from the epoxide compound or comprising at least one unit derived from the epoxide compound and at least two units derived from the isocyanate compound.
  • the chain length of the polyoxazolidinone compounds can be controlled by adjusting the ratio between the diisocyanate and the diepoxide compound.
  • An isocyanate terminated oligomer is obtained, when the diisocyanate is employed in excess.
  • An epoxide terminated oligomer is obtained, when the diepoxide is employed in excess.
  • Linear polymer chains with high molecular weight are obtained, when equimolar amounts of diisocyanate and diepoxide are reacted with one another.
  • the precise content of isocyanate and epoxide groups in the diisocyanate and diepoxide, respectively, are preferentially determined before the polymerisation reaction, e.g., by measuring the isocyanate number according to German standard norm DIN EN ISO 11909 and the epoxide number according to German standard norm DIN EN 1877-1.
  • the number average molecular weight M n of the polyoxazolidinone compound may be, for example, in the range of > 320 g/mol to ⁇ 10 ⁇ 00 ⁇ 00 g/mol, preferably > 480 g/mol to ⁇ 600 ⁇ 00 g/mol and most preferably > 2 ⁇ 00 g/mol to ⁇ 200 ⁇ 00 g/mol, as determined with gel permeation chromatography (GPC).
  • GPC gel permeation chromatography
  • Another method suitable to determine the molecular weight of the polyoxazolidinone compounds is based on end-group analysis with 'H-NMR spectroscopy.
  • An alternative method to control the molecular weight of the products constitutes in adding a small amount of a monoepoxide or monoisocyanate to the mixture of polyepoxide and the polyisocyanate compound.
  • the monoepoxide or monoisocyanate compound can be added at the beginning of the reaction of polyepoxide and polyisocyanate compound, during the reaction of polyepoxide and polyisocyanate compound or after the reaction of polyepoxide and polyisocyanate compound is completed.
  • this oligomeric or polymeric oxazolidinone compound comprises at least one, preferably at least two and particularly preferred two terminal epoxide and/or isocyanate groups. It is also possible that this oligomeric or polymeric oxazolidinone compound comprises at least one terminal group which is non-reactive towards epoxide and/or isocyanate groups. Examples include alkoxy groups or trialkylsiloxane groups.
  • the method according to the invention is suited for the synthesis of oxazolidinone compounds with interesting properties for use, for example, as pharmaceutics or antimicrobiotics.
  • Polyoxazolidinones obtained by the method according to the invention are particularly suited as polymer building blocks in polyurethane chemistry.
  • epoxy-terminated oligomeric oxazolidinones oligooxazolidinones
  • Such epoxy-terminated oligomeric oxazolidinones are also suited for the preparation of composite materials.
  • Epoxy-terminated oligomeric oxazolidinones may also be reacted with their NCO-terminated counterparts to form high molecular weight polyoxazolidinones, which are useful as transparent, high temperature-stable materials.
  • Polyoxazolidinones with high molecular weight obtained by the method according to the invention are particularly suited as transparent, high temperature-stable thermoplastic materials.
  • para-To ⁇ y ⁇ isocyanate purity 99%; distilled in a partial vacuum (200 mbar, 80 °C) and stored under argon at -4 °C prior to use, Acros Organics, Belgium.
  • Diisocyanate 1 2,4-Toluenediisoyanate, >99 % 2,4-isomer, Bayer MaterialScience AG, Germany
  • R-(+)-Styrene oxide was distilled in a partial vacuum (200 mbar, 80 °C) prior to use.
  • Diepoxide 1 Bisphenol-A-diglycidylether (4,4'-isopropylidenediphenol diglycidyl ether, Epikote Resin 162), purity +99%, stored at room temperature, Momentive, Germany
  • NMP N-Methylpyrrolidinone
  • the 300 ml pressurized reactor used in the synthesis of polyoxazolidinones had a height (internal) of 10.16 cm and an internal diameter of 6.35 cm.
  • the reactor was fitted with an electric heating jacket (510 watt maximum heating capacity).
  • the counter cooling consisted of a U-shaped dip tube with an external diameter of 6 mm, which projected into the reactor to within 5 mm of the bottom and through which cooling water at approximately 10°C was passed. The water stream was switched on and off by means of a solenoid valve.
  • the reactor was also fitted with an inlet tube and a temperature probe of 1.6 mm diameter, both of which projected into the reactor to within 3 mm of the bottom.
  • the impeller agitator used in the examples was a pitched-blade turbine to which a total of two agitator stages, each with four agitator blades (45°) of 35 mm diameter and 10 mm height, were attached to the agitator shaft at a distance of 7 mm.
  • pulse addition corresponding to the step-wise addition mode of the isocyanate, means that the isocyanate compound is added in individual steps, comprising a part of the total amount of the isocyanate compound, to the reaction mixture.
  • IR In-situ Infrared
  • the composition of the reaction mixtures was followed with a Bruker MATRIX-MF spectrometer equipped with a high-pressure attenuated total reflectance (ATR) IR fibre optical probe.
  • the ATR IR fibre optical probe (3.17 mm outer diameter, 90° diamond prism with 1 x 2 mm basal area and 1 mm height as ATR element, 2 ⁇ 45° reflection of the IR beam, IR beam coupled via fibre optics) was fitted into the reactor in such a way that the diamond at the end of the optical probe was immersed entirely into the reaction mixture.
  • IR spectra (average of 20 scans, if not stated otherwise) were recorded time-resolved in the region of 3500-650 cm “1 with a resolution of 4 cm “1 at 60 second time intervals (if not stated otherwise).
  • the spectra were analysed with the software PEAXACT 3.1 - Software for Quantitative Spectroscopy and Chromatography, S'PACT GmbH using the Integrated Hard Model (IHM) method.
  • the hard model for analysing the IR spectra of the reaction mixtures was created by linear combination of hard models for the single components monoisocyanate, oxazolidinone and isocyanurate.
  • the hard model for the single components was created as follows:
  • a 10 mL glass flask containing 5 mL propylene carbonate was immersed into an oil bath preheated to 160 °C.
  • a background IR spectrum (average of 100 scans) was measured against air.
  • the IR probe was then inserted into the glass flask in such a way that the diamond at the end of the optical probe was immersed entirely into the reaction mixture.
  • the glass flask was capped with a rubber seal and another background IR spectrum was measured (average of 100 scans).
  • monoisocyanate 1 (0.37 mL, 2.95 mmol, 5 mol% relative to propylene carbonate) was injected with a microliter syringe through the seal into the reaction mixture and several IR spectra were recorded of the resulting mixture.
  • the relevant signals in the region 2150 to 2400 cm “1 were selected from a representative IR spectrum and the model refined to achieve an optimum fit between a superposition of the selected signals and the averaged IR spectra of the mixture.
  • a 10 mL glass flask containing 0.5 mL propylene carbonate was immersed into an oil bath preheated to 160 °C.
  • a background IR spectrum (average of 100 scans) was measured against air.
  • the IR probe was then inserted into the glass flask in such a way that the diamond at the end of the optical probe was immersed entirely into the reaction mixture.
  • the glass flask was capped with a rubber seal and another background IR spectrum was measured (average of 100 scans).
  • a 10 mL glass flask containing 0.5 mL propylene carbonate was immersed into an oil bath preheated to 160 °C.
  • a background IR spectrum (average of 100 scans) was measured against air.
  • the IR probe was then inserted into the Schlenk flask in such a way that the diamond at the end of the optical probe was immersed entirely into the reaction mixture.
  • the Glass flask was capped with a rubber seal and another background IR spectrum was measured (average of 100 scans).
  • the turnover frequency (TOF1/2) was determined according to equation 1, TOF . " “ ⁇ : “ , “ : ⁇ (eq. l)
  • n co,to is the molar amount of isocyanate in the reaction mixture after injection of the second isocyanate pulse
  • nNco,ti/2 is the residual molar amount of isocyanate observed by in-situ IR spectroscopy at ti 2 after injection of the second isocyanate pulse
  • n cat is the molar amount of catalyst in the reaction mixture after injection of the second isocyanate pulse.
  • n fm oxA is the molar amount of oxazolidinone moieties at the end of the reaction and n fm icT is the molar amount of isocyanurate groups at the end of the reaction.
  • Solid state IR analyses were performed on a Bruker ALPHA-P IR spectrometer equipped with a diamond probe head. A background spectrum was recorded against ambient air. Thereafter, a small sample of the oxazolidinone (2 milligrams) was applied to the diamond probe and the IR spectrum recorded averaging over 32 spectra obtained in the range of 4000 to 400 cm “1 with a resolution of 4 cm “1 .
  • the software OPUS 6.5 was used for data treatment.
  • the molar fraction of the two regioisomers in the oxazolidinone product was determined by HPLC chromatography (monooxazolidinones) or 3 ⁇ 4 NMR spectroscopy (polyoxazolidinones) as described below.
  • the regioselectivity RS-OXA was then calculated according to the following equation 3 :
  • XS OXA is the molar fraction of 5-substituted l,3-oxazolidin-2-one (5-OXA) moieties at the end of the reaction and X4-OXA is the molar fraction of 4-substituted l,3-oxazolidin-2-one (4-OXA) moieties at the end of the reaction.
  • the HPLC analyses were carried out on an Agilent Technologies 1200 Series instrument equipped with an UV detector and a Waters SymmetryShield RPis column (particle size 5 ⁇ , pore size 100 A). The temperature of the column was kept constant at 40 °C throughout the measurement. A water-methanol solvent system (flow rate of 1.0 mL/min) was used for separation of the components of the reaction mixture. The reaction mixture (10 mg) and mesitylene (5 ⁇ ) were dissolved in methanol (1 ml) and a defined volume of the mixture injected onto the column. An isocratic condition with a water-to-methanol ratio of 60:40 was maintained for 20 min.
  • the average chain length of the polyoxazolidinones was adjusted by the relative molar ratio of the diisocyanate and diepoxide used in the particular reaction.
  • Equation 4 (eq.4) below gives a general mathematical formula to calculate the average chain length n in the oligomeric and/or polymeric product based on the molar ratios of diisocyanate and diepoxide compound employed.
  • n 1 / [ ⁇ (amount of diepoxide in mol) / (amount of diisocyanate in mol) ⁇ - 1 ] (eq. 4)
  • Equation 5 (eq. 5) below gives a general mathematical formula to calculate the average chain length n in the oligomeric and/or polymeric product based on the molar ratios of diisocyanate and diepoxide compound employed.
  • n 1 / [ ⁇ (amount of isocyanate in mol) / (amount of epoxide in mol) ⁇ - 1 ] (eq. 5)
  • the ratio of the two regioisomers in the polyoxazolidinone product was determined by l H NMR spectroscopy.
  • a representative example of the polyoxazolidinone structure is represented by the formula (III) shown below.
  • the formula weight (FW) of the end-groups and the repeating unit is given, based on
  • the regioselectivity RS-OXA was calculated from the integrals of the signals Sl-1 andSl-2 using the following equation 6:
  • GPC Gel permeation chromatography
  • thermogravimetric analysis TGA
  • the measurements were performed on a Mettler Toledo TGA/DSC 1.
  • the sample (6 to 20 mg) was heated from 25 °C to 600 °C with a heating rate of 10 K/min and the relative weight loss followed in dependence of temperature.
  • the software STAR 6 SW 1 1.00 was used. As decomposition temperature the inflection point of the sinuidal weight loss curve is stated.
  • the glass transition point was recorded on a Mettler Toledo DSC 1.
  • the sample (4 to 10 mg) was heated from 25°C to 250 °C with a heating rate of 10 K/min.
  • the software STAR 6 SW 1 1.00 was used for data analysis.
  • For determination of the glass transition temperature a tangential analysis method was used. The midpoint of the intersection point between the tangent at low temperature and the tangent in the mid temperature range and the intersection point between the tangent in the mid temperature range and the tangent at high temperature is stated.
  • a glass flask (20 mL) was charged with 4-bromoanisol (381.5 mg, 2.04 mmol), ⁇ 13 ⁇ 4 (562 mg, 2.14 mmol), NiBr2 (22.3 mg, 0.10 mmol) and ethylene glycol (0.68 mL, 12.19 mmol).
  • the mixture was stirred (600 rpm) at room temperature for 10 min using a magnetic stirrer bar of 0.3 cm length.
  • the flask was then placed into a hot oil bath set to 180 °C for 20 minutes. The heating of the oil bath was then switched off and the reaction mixture cooled to room temperature within of 30 min.
  • Dichloromethane 35 mL was added to the crude reaction mixture and the organic layer was washed three times with water and once with brine, dried over MgSO i, filtered and the solvent partially removed under partial vacuum. A brown highly viscous fluid was obtained, which was diluted with dichloromethane (ca. 2 mL). Diethylether (15 mL) was added to this mixture, while shaking the flask vigorously. A white precipitate was obtained, which was collected, washed two times with diethylether and dried in a partial vacuum to afford the product as a white solid.
  • Example 1 Reaction of R-(+)-styrene oxide with para-tolyl isocyanate using [PPhs ⁇ p- C 6 H 4 (OMe) ⁇ ]Br (1-1) as catalyst
  • a first pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a second pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.91 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a third pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • the heating of the oil bath was switched off and the reaction mixture cooled to room temperature within of 45 min. The chemical composition of the reaction mixture was analysed.
  • HPLC analysis confirmed full conversion of R-(+)-styrene oxide and para-to ⁇ y ⁇ isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone compound was 100 %. Signals due to the presence of other side products like carbodiimids and homo-polymers of the epoxides were not observed.
  • the regioselectivity RS-OXA (HPLC) towards the 5-oxazolidinone (5-OXA) regioisomer was 88 %.
  • a first pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a second pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.91 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a third pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • the heating of the oil bath was switched off and the reaction mixture cooled to room temperature within of 30 min.
  • the chemical composition of the reaction mixture was analysed. TOFi/2 with respect to conversion of the isocyanate was 580 h "1 .
  • HPLC analysis confirmed full conversion of R-(+)-styrene oxide and para-tolyl isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone compound was 100 %. Signals due to the presence of other side products like carbodiimides and homo-polymers of the epoxides were not observed.
  • a first pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a second pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.91 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a third pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • the heating of the oil bath was switched off and the reaction mixture cooled to room temperature within of 30 min.
  • the chemical composition of the reaction mixture was analysed. TOFi/2 with respect to conversion of the isocyanate was 762 h "1 .
  • HPLC analysis confirmed full conversion of R-(+)-styrene oxide and para-to ⁇ y ⁇ isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone was 100 %. Signals due to the presence of other side products like carbodiimides and homo-polymers of the epoxides were not observed.
  • the regioselectivity RS-OXA (HPLC) towards the 5-oxazolidinone regioisomer was 80 %.
  • Example 4 Reaction of R-(+)-styrene oxide with para-tolyl isocyanate using PPh4Br (1-3) as catalyst
  • a first pulse of para-tolyl isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a second pulse of para-tolyl isocyanate (0.388 g, 2.91 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a third pulse of para-tolyl isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • the heating of the oil bath was switched off and the reaction mixture cooled to room temperature within of 30 min.
  • the chemical composition of the reaction mixture was analysed. TOFi/2 with respect to conversion of the isocyanate was 552 h "1 .
  • HPLC analysis confirmed full conversion of R-(+)-styrene oxide and para-tolyl isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone was 100 %. Signals due to the presence of other side products like carbodiimides and homo-polymers of the epoxides were not observed.
  • the regioselectivity RS-OXA (HPLC) towards the 5-oxazolidinone regioisomer was ⁇ 78 %.
  • Example 5 Reaction of R-(+)-styrene oxide with para-tolyl isocyanate using [P( «-Bu) i]Br (1-4) as catalyst
  • a first pulse of para-tolyl isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a second pulse of para-tolyl isocyanate (0.388 g, 2.91 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a third pulse of para-tolyl isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • the heating of the oil bath was switched off and the reaction mixture cooled to room temperature within of 30 min.
  • the chemical composition of the reaction mixture was analysed. TOFi/2 with respect to conversion of the isocyanate was 410 h "1 .
  • HPLC analysis confirmed full conversion of R-(+)-styrene oxide and para-tolyl isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone was 100 %. Signals due to the presence of other side products like carbodiimides and homo-polymers of the epoxides were not observed.
  • Example 6 Reaction of 1 ,2-epoxy-3-phenoxy propane with para-tolyl isocyanate using 1-1 as catalyst
  • a first pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a second pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.91 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • a third pulse of para-to ⁇ y ⁇ isocyanate (0.388 g, 2.92 mmol) was added quickly (within of 2 s) and the reaction mixture stirred until completion of the reaction was indicated by disappearance of the isocyanate band.
  • the heating of the oil bath was switched off and the reaction mixture cooled to room temperature within of 30 min. The chemical composition of the reaction mixture was analysed.
  • HPLC analysis confirmed full conversion of l,2-epoxy-3-phenoxy propane and para-to ⁇ y ⁇ isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone was 100 %. Signals due to the presence of other side products like carbodiimides and homo-polymers of the epoxides were not observed.
  • the regioselectivity RS-OXA (HPLC) towards the 5-oxazolidinone regioisomer was 100 %.
  • Examples 1 and 6 show that independent of the choice of the epoxide a similar rate is obtained.
  • Example 7 Reaction of R-(+)-styrene oxide with para-tolyl isocyanate using [PPh ⁇ (cyclohexyl)]Br (1-6) as catalyst at a higher reaction temperature
  • Example 3 was repeated as described above, whereby the reaction was conducted at a temperature of 200 °C.
  • HPLC analysis confirmed full conversion of R-(+)-styrene oxide and para-to ⁇ y ⁇ isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone was 95%. Signals due to the presence of other side products like carbodiimides and homo-polymers of the epoxides were not observed.
  • the regioselectivity RS-OXA (HPLC) towards the 5-oxazolidinone regioisomer was 85%.
  • Example 8 Reaction of R-( +)-styrene oxide with para-tolyl isocyanate using PPh 4 Br (1-3) as catalyst at a higher reaction temperature
  • Example 4 (comp.) was repeated as described above, whereby the reaction was conducted at a temperature of 200 °C.
  • HPLC analysis confirmed full conversion of R-(+)-styrene oxide and para-tolyl isocyanate.
  • the chemoselectivity SOXA (HPLC) for the formation of the oxazolidinone was 88 %. Signals due to the presence of other side products like carbodiimides and homo-polymers of the epoxides were not observed.
  • Examples 3 and 7 show that independent of the reaction temperature the oxazolidinone product is obtained with a higher rate (TOF1/2), when phosphonium salts with an unsymmetric substitution pattern are used, in comparison to comparative examples 4 and 8, in which a phosphonium salt with a symmetric substitution pattern was used.
  • TOF1/2 reaction temperature
  • the regioselectivity towards the 5-oxazolidinone regioisomer obtained in examples 3 to 7 using onium salts according to the invention were higher compared to comparative examples 4 and 8.
  • the reaction was performed in a 300 ml stainless steel autoclave as described above with a motor with a stirring power of 90 W.
  • the reactor was charged with diepoxide 1 (BADGE, 15.0 g, 44.1 mmol) and catalyst 1-2 (154 mg, 0.42 mmol) and subsequently flushed three times with argon.
  • Diepoxide 1 BADGE, 15.0 g, 44.1 mmol
  • catalyst 1-2 154 mg, 0.42 mmol
  • argon After addition of dry NMP (40 ml), the reactor was sealed and the mixture was heated to 200 °C under rapid stirring (1000 rpm). After 200 °C had been obtained, a solution of diisocyanate 1 (TDI, 7.3 g, 41.97 mmol) in dry NMP (15 ml) was added with an HPLC pump (10 ml pump head) over 3 h.
  • TDI diisocyanate 1
  • reaction mixture After an overall reaction time of 19 h (starting with the addition of diisocyanate 1), the reaction mixture was cooled to room temperature. The reaction mixture was poured into methanol. The precipitate was collected and washed three times with methanol and subsequently with diethylether. The obtained powder was dried at 5x 10 "2 mbar for 4 hours.
  • the regioselectivity RS-OXA (NMR) towards the 5-substituted l,3-oxazolidin-2-one regioisomer was > 96 %.
  • Example 9 shows that polyoxazolidinone compounds are obtained, when onium salts according to the invention are used as catalyst in the reaction of diisocyanate compounds with diepoxide compounds.
  • Example 10 Reaction of 2,4-toluenediisocyanate (TDI) with 4,4'-isopropylidenediphenol diglycidyl ether (BADGE) using (1-1) as catalyst followed by reaction of the product with para-tolyl isocyanate
  • TDI 2,4-toluenediisocyanate
  • BADGE 4,4'-isopropylidenediphenol diglycidyl ether
  • the reaction was performed in a 300 ml stainless steel autoclave as described above with a motor with a stirring power of 90 W.
  • the reactor was charged with diepoxide 1 (15.0 g, 44.1 mmol) and catalyst 1-1 (0.2g, 0.44 mmol) and subsequently flushed with Argon.
  • After addition of dry NMP (40 ml) the reactor was sealed and the mixture was heated to 200 °C under rapid stirring (1000 rpm). After 200 °C had been obtained, a solution of diisocyanate 1 (7.3 g, 41.97 mmol) in dry NMP (15 ml) was added with an HPLC pump (10 ml pump head) over 3 h.
  • the regioselectivity RS-OXA (NMR) towards the 5-substituted l,3-oxazolidin-2-one regioisomer was > 95 %.
  • Example 10 shows that polyoxazolidinone compounds are obtained, when onium salts according to the invention are used as catalyst in the reaction of diisocyanate compounds with diepoxide compounds followed by reaction of the obtained product with a monoisocyanate compound in the presence of the same catalyst.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Polyurethanes Or Polyureas (AREA)
EP15723462.6A 2014-05-12 2015-05-07 Katalysatoren für die synthese von oxazolidinonverbindungen Active EP3143060B8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14167823 2014-05-12
EP15154978 2015-02-13
PCT/EP2015/060062 WO2015173111A1 (en) 2014-05-12 2015-05-07 Catalysts for the synthesis of oxazolidinone compounds

Publications (3)

Publication Number Publication Date
EP3143060A1 true EP3143060A1 (de) 2017-03-22
EP3143060B1 EP3143060B1 (de) 2020-06-24
EP3143060B8 EP3143060B8 (de) 2020-10-28

Family

ID=53189791

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15723462.6A Active EP3143060B8 (de) 2014-05-12 2015-05-07 Katalysatoren für die synthese von oxazolidinonverbindungen

Country Status (4)

Country Link
US (1) US20170081462A1 (de)
EP (1) EP3143060B8 (de)
CN (1) CN106459331B (de)
WO (1) WO2015173111A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019073034A1 (de) 2017-10-13 2019-04-18 Covestro Deutschland Ag Verfahren zur herstellung eines vernetzbaren polymers unter bildung von oxazolidinonen

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11326018B2 (en) 2016-08-19 2022-05-10 Covestro Deutschland Ag Process for the synthesis of polyoxazolidinone compounds
US11180603B2 (en) 2017-02-16 2021-11-23 Basf Se Polyoxazolidones and production thereof
EP3456753A1 (de) * 2017-09-15 2019-03-20 Covestro Deutschland AG Verfahren zur herstellung von thermoplastischen polyoxazolidinonpolymeren
WO2019063391A1 (de) 2017-09-29 2019-04-04 Basf Se Thermoplastische polyoxazolidone aus diisocyanten und diglycidylether von 2-phenyl-1,3-propandiol-derivaten
MX2020004288A (es) * 2017-10-27 2020-07-29 Huntsman Int Llc Catalizadores para elaborar materiales de oxazolidinona.
WO2020016276A1 (de) 2018-07-18 2020-01-23 Basf Se Bulkpolymerisierung von polyoxazolidon
EP3640276A1 (de) * 2018-10-16 2020-04-22 SABIC Global Technologies B.V. Hochhitzebeständige epoxidterminierte polyoxazolidone, zusammensetzungen, verfahren zur herstellung und verwendungen davon
WO2022136046A1 (en) 2020-12-21 2022-06-30 Basf Se Thermoplastic polyoxazolidinone having a high temperature stability
EP3964536A1 (de) 2021-02-23 2022-03-09 Basf Se Polyoxazolidinon zwischenprodukt enthaltend ein antioxidans
WO2022228955A1 (en) 2021-04-26 2022-11-03 Covestro Deutschland Ag Method for the production of an isocyanate-group terminated polyoxazolidinone composition
EP4083100A1 (de) * 2021-04-26 2022-11-02 Covestro Deutschland AG Verfahren zur herstellung einer isocyanatgruppenterminierten polyoxazolidinonzusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687897A (en) * 1970-06-22 1972-08-29 Dow Chemical Co Preparation of oxazolidinones by reacting an isocyanate, or isothiocyanate with an epoxide in the presence of a phosphonium halide acid, ester, or acid ester of the element c
US4658007A (en) * 1985-05-07 1987-04-14 The Dow Chemical Company Polyisocyanurate-based polyoxazolidone polymers and process for their preparation
DE3720759A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Oxazolidongruppen enthaltende epoxidharze
EP0342064B1 (de) * 1988-05-13 1995-02-15 Nippon Paint Co., Ltd. Hitzehärtende Harzzusammensetzung und Herstellung von hitzebeständigen Überzügen und Gegenständen auf der Basis dieser Zusammensetzung
CA2891200A1 (en) * 2012-11-14 2014-05-22 Bayer Materialscience Ag Method for the production of oxazolidinone compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019073034A1 (de) 2017-10-13 2019-04-18 Covestro Deutschland Ag Verfahren zur herstellung eines vernetzbaren polymers unter bildung von oxazolidinonen

Also Published As

Publication number Publication date
CN106459331B (zh) 2019-09-13
US20170081462A1 (en) 2017-03-23
CN106459331A (zh) 2017-02-22
WO2015173111A1 (en) 2015-11-19
EP3143060B8 (de) 2020-10-28
EP3143060B1 (de) 2020-06-24

Similar Documents

Publication Publication Date Title
EP3143060B1 (de) Katalysatoren für die synthese von oxazolidinonverbindungen
EP3143059B1 (de) Katalysatoren für die synthese von oxazolidinonverbindungen
EP2920218B1 (de) Verfahren zur herstellung von oxazolidinonverbindungen
EP3143065B1 (de) Verfahren zur herstellung von polyoxazolidinon-polymerverbindungen
JP6698095B2 (ja) 高い安定性を有するポリオキサゾリジノン化合物の合成方法
JP2004250662A (ja) モノマー含有量の少ないtdi三量体の製造方法
CN107849219B (zh) 基于1,5-五亚甲基二异氰酸酯的封端多异氰酸酯组合物
US20220204684A1 (en) Method for the production of isocyanate-group terminated polyoxazolidinones
US20220227919A1 (en) Method for the production of epoxy-group terminated polyoxazolidinones
CN104479103B (zh) 一种高官能度的聚氨酯固化剂、该固化剂的制备方法及其用途
KR940000057B1 (ko) 지환식 디아민 및 그 제조방법
JPS5922916A (ja) 脂肪族ポリイソシアヌレ−ト重合体の製造方法
JP2840095B2 (ja) ポリイソシアナート―イソシアヌレートおよびその製造法
KR930004792B1 (ko) 폴리이소시아네이토 알킬페닐-이소시아누레이트 및 그의 제조방법

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20161212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190801

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20200110

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20200219

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1283824

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200715

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015054684

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNGEN

RIN2 Information on inventor provided after grant (corrected)

Inventor name: BASU, SUSMIT

Inventor name: LATORRE, IRENE

Inventor name: MUELLER, THOMAS ERNST

Inventor name: GUERTLER, CHRISTOPH

Inventor name: RANGHEARD, CLAUDINE

Inventor name: LEITNER, WALTER

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602015054684

Country of ref document: DE

Owner name: COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG, DE

Free format text: FORMER OWNER: COVESTRO DEUTSCHLAND AG, 51373 LEVERKUSEN, DE

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: COVESTRO DEUTSCHLAND AG

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNG B8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200924

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200925

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200924

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1283824

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200624

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201026

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201024

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015054684

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20210325

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20210507

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210531

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210507

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210507

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210507

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210531

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20220502

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20220502

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20150507

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230418

Year of fee payment: 9

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20230601

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20230531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200624